Michelle Doig

Michelle Doig is a Partner and Head of Corporate Development at Omega Funds, a leading international investment firm focused on life sciences companies.13 She joined Omega Funds in 2016 and has over 20 years of experience advising life sciences companies on private placements, public equity financing, and M&A transactions.23

Prior to joining Omega Funds, Michelle held several notable positions:

1. Director of Corporate Finance at Third Rock Ventures, supporting portfolio companies2
2. Principal of Corporate Finance at Abingworth2
3. Life sciences investment banker at:
   • Lehman Brothers International in London
   • JP Morgan/H&Q in New York
   • Morgan Stanley in Toronto and New York2

Throughout her career, Michelle has executed more than 40 equity and convertible transactions, as well as numerous IPOs, private placements, and M&A transactions for companies including Gilead, MedImmune, Millennium, Illumina, and Sepracor.2

Michelle graduated with an Honor's degree in Business Administration from the Richard Ivey School of Business at the University of Western Ontario in London.2 Her LinkedIn profile can be found under the username michelle-doig-934ba88.4